ARCHIVES

Risk Assessment Key In Long-Term Treatment

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

Center Directors, NCI Staff Agree- They Have Problems

November 26, 1976

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

April 11, 2003